Lipella Pharmaceuticals Inc. (NASDAQ: LIPO) Stock Information | RedChip

Lipella Pharmaceuticals Inc. (NASDAQ: LIPO)
Listen to this Section


$0.48
-0.0297 ( -5.85% ) 491.2K

Lipella Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is focused on developing new drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for new applications. The company's product candidates include LP-10, LP-310 and LP-410 which can be helpful in treatment of Hemorrahagic Cystitis, Oral Licen Planus and Oral Graft.

Market Data


Open


$0.48

Previous close


$0.51

Volume


491.2K

Market cap


$3.98M

Day range


$0.44 - $0.50

52 week range


$0.32 - $2.71

Insider Ownership Transactions

Total Amount Purchased: -144,906.00

Date Type Amount Purchased Purchaser
2024-03-15 Sale -144906.00 Chancellor Michael B

SEC Fillings


Form Type Description Pages Date
10-q Quarterly Reports 65 Aug 13, 2024
def Proxies and info statements 3 Aug 12, 2024
ars Annual reports 1 Aug 12, 2024
8-k 8K-related 13 Aug 06, 2024
8-k 8K-related 23 Aug 01, 2024
pre Proxies and info statements 3 Jul 30, 2024
4 Insider transactions 1 May 15, 2024
10-q Quarterly Reports 65 May 09, 2024
8-k 8K-related 13 Apr 19, 2024
8-k 8K-related 17 Apr 12, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.